Eu Tiong Chua

1.3k total citations · 1 hit paper
20 papers, 981 citations indexed

About

Eu Tiong Chua is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Otorhinolaryngology. According to data from OpenAlex, Eu Tiong Chua has authored 20 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 8 papers in Surgery and 7 papers in Otorhinolaryngology. Recurrent topics in Eu Tiong Chua's work include Head and Neck Cancer Studies (7 papers), Glioma Diagnosis and Treatment (4 papers) and Brain Metastases and Treatment (4 papers). Eu Tiong Chua is often cited by papers focused on Head and Neck Cancer Studies (7 papers), Glioma Diagnosis and Treatment (4 papers) and Brain Metastases and Treatment (4 papers). Eu Tiong Chua collaborates with scholars based in Singapore, Australia and Thailand. Eu Tiong Chua's co-authors include Kam Weng Fong, Joseph Wee, Vijay Sethi, E. Chua, Eng Huat Tan, Terence Tan, Susan Loong, Hwee Bee Wong, Edward S. Yang and David Machin and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Eu Tiong Chua

20 papers receiving 971 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety

2005 496 citations Joseph Wee, Eng Huat Tan et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eu Tiong Chua Singapore	10	749	534	410	348	94	20	981
Chunying Shen China	19	593 0.8×	395 0.7×	461 1.1×	294 0.8×	168 1.8×	60	945
Xiayun He China	19	701 0.9×	461 0.9×	420 1.0×	293 0.8×	165 1.8×	96	1.1k
Xiaoshen Wang China	17	573 0.8×	346 0.6×	307 0.7×	271 0.8×	82 0.9×	53	793
Hai‐Qiang Mai China	16	872 1.2×	564 1.1×	583 1.4×	337 1.0×	171 1.8×	57	1.2k
Michael K. M. Kam Hong Kong	9	1.1k 1.4×	730 1.4×	422 1.0×	531 1.5×	61 0.6×	15	1.3k
Yi-Jun Hua China	15	575 0.8×	405 0.8×	335 0.8×	256 0.7×	104 1.1×	18	807
Hongmei Ying China	14	381 0.5×	258 0.5×	214 0.5×	159 0.5×	51 0.5×	38	578
Tai-Xiang Lu China	24	1.6k 2.1×	1.1k 2.0×	743 1.8×	701 2.0×	177 1.9×	38	1.9k
Avraham Eisbruch United States	10	331 0.4×	254 0.5×	182 0.4×	273 0.8×	37 0.4×	13	665
Merril Kies United States	10	320 0.4×	295 0.6×	248 0.6×	271 0.8×	35 0.4×	10	607

Countries citing papers authored by Eu Tiong Chua

Since Specialization

Citations

This map shows the geographic impact of Eu Tiong Chua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eu Tiong Chua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eu Tiong Chua more than expected).

Fields of papers citing papers by Eu Tiong Chua

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eu Tiong Chua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eu Tiong Chua. The network helps show where Eu Tiong Chua may publish in the future.

Co-authorship network of co-authors of Eu Tiong Chua

This figure shows the co-authorship network connecting the top 25 collaborators of Eu Tiong Chua. A scholar is included among the top collaborators of Eu Tiong Chua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eu Tiong Chua. Eu Tiong Chua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, You‐Quan, Whee Sze Ong, Wen Long Nei, et al.. (2022). Cardiovascular toxicities of androgen deprivation therapy in Asian men with localized prostate cancer after curative radiotherapy: a registry-based observational study. Cardio-Oncology. 8(1). 1 indexed citations

Sultana, Rehena, et al.. (2021). A Prospective Randomized Controlled Trial to Compare the Use of Conventional Dark-Ink Tattoo and Ultraviolet-Ink Tattoo for Patients Undergoing Breast Radiation Therapy. Practical Radiation Oncology. 11(6). 463–469. 9 indexed citations

Li, You‐Quan, Siqin Zhou, Melvin L.K. Chua, et al.. (2021). A comparative analysis between low-dose-rate brachytherapy and external beam radiation therapy for low- and intermediate-risk prostate cancer in Asian men. Acta Oncologica. 60(10). 1291–1295. 3 indexed citations

Knight, Kellie, Sung Yong Park, Zubin Master, et al.. (2020). Duration-dependent margins for prostate radiotherapy—a practical motion mitigation strategy. Strahlentherapie und Onkologie. 196(7). 657–663. 4 indexed citations

Lim, Cindy, Melvin L.K. Chua, Kevin Lee Min Chua, et al.. (2020). Randomised prospective phase II trial in multiple brain metastases comparing outcomes between hippocampal avoidance whole brain radiotherapy with or without simultaneous integrated boost: HA-SIB-WBRT study protocol. BMC Cancer. 20(1). 1045–1045. 12 indexed citations

Li, You‐Quan, Eu Tiong Chua, Kevin Lee Min Chua, & Melvin L.K. Chua. (2018). “Cor Occidere”: a novel strategy of targeting the tumor core by radiosurgery in a radio- and chemo-resistant intracranial hemangiopericytoma. Chinese Clinical Oncology. 7(1). 10–10. 1 indexed citations

Chua, Eu Tiong, et al.. (2018). Long-Term Disease-Free Survival of a Patient with Oligometastatic Nasopharyngeal Carcinoma Treated with Radiotherapy Alone. Case Reports in Oncology. 11(2). 392–398. 3 indexed citations

Chua, Melvin L.K., Grace Kusumawidjaja, Whee Sze Ong, et al.. (2016). Dose-escalated intensity-modulated radiotherapy and irradiation of subventricular zones in relation to tumor control outcomes of patients with glioblastoma multiforme. OncoTargets and Therapy. 9. 1115–1115. 16 indexed citations

Chua, Melvin L.K., et al.. (2014). Dose-escalated intensity modulated radiotherapy (IMRT) and increased radiation doses to subventricular zones (SVZ) in treatment outcomes of patients with glioblastoma multiforme (GBM).. Journal of Clinical Oncology. 32(15_suppl). e13031–e13031. 5 indexed citations

10.

Chua, Eu Tiong, et al.. (2013). Frameless linac-based stereotactic radiosurgery treatment for SUNCT syndrome targeting the trigeminal nerve and sphenopalatine ganglion. Cephalalgia. 33(13). 1132–1136. 6 indexed citations

11.

Tuan, Jeffrey, Tam Ha, Whee Sze Ong, et al.. (2012). Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma. Radiotherapy and Oncology. 104(3). 305–311. 69 indexed citations

12.

Tham, Chee Kian, Siew Ju See, Sze Huey Tan, et al.. (2012). Combined temozolomide and radiation as an initial treatment for anaplastic glioma. Asia-Pacific Journal of Clinical Oncology. 9(3). 220–225. 6 indexed citations

13.

Wong, Fuh Yong, et al.. (2011). Implications of HER2 Amplification in Small, Node‐Negative Breast Cancers: Do Asians Differ?. World Journal of Surgery. 36(2). 287–294. 6 indexed citations

14.

Wong, Fuh Yong, et al.. (2011). Hormone Receptors and HER-2 Status as Surrogates for Breast Cancer Molecular Subtypes Prognosticate for Disease Control in Node Negative Asian Patients Treated with Breast Conservation Therapy. Annals of the Academy of Medicine Singapore. 40(2). 90–96. 17 indexed citations

15.

Yeo, R., Kam Weng Fong, Siew Wan Hee, et al.. (2009). Brachytherapy boost for T1/T2 nasopharyngeal carcinoma. Head & Neck. 31(12). 1610–1618. 14 indexed citations

16.

Tham, Ivan Weng Keong, Siew Wan Hee, R. Yeo, et al.. (2009). Treatment of Nasopharyngeal Carcinoma Using Intensity-Modulated Radiotherapy—The National Cancer Centre Singapore Experience. International Journal of Radiation Oncology*Biology*Physics. 75(5). 1481–1486. 195 indexed citations

17.

Puan, Kia Joo, Joseph Wee, Eng Huat Tan, et al.. (2008). Phenotypic and functional alterations of Vγ2Vδ2 T cell subsets in patients with active nasopharyngeal carcinoma. Cancer Immunology Immunotherapy. 58(7). 1095–1107. 16 indexed citations

18.

Chua, Melvin L.K., Seng Chuan Ong, Joseph Wee, et al.. (2008). Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma. Head & Neck. 31(3). 346–354. 60 indexed citations

19.

Wee, Joseph, Eng Huat Tan, Bee Choo Tai, et al.. (2005). Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety. Journal of Clinical Oncology. 23(27). 6730–6738. 496 indexed citations breakdown →

20.

Tan, E.H., Eu Tiong Chua, Joseph Wee, et al.. (1999). Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: toxicities and preliminary results. International Journal of Radiation Oncology*Biology*Physics. 45(3). 597–601. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact